U
Isracann Biosciences Inc. ISCNF
$0.00 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

08/31/2022 05/31/2022 02/28/2022 11/30/2021 08/31/2021
Total Cash And Short-Term Investments -86.31% -89.57% -86.56% -58.51% -56.21%
Total Receivables -66.12% -62.01% -42.02% 110.32% -44.66%
Inventory -- -- -- -- --
Prepaid Expenses -13.37% -45.64% -3.81% -3.49% -85.97%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -82.30% -85.38% -81.04% -53.87% -59.57%

Total Current Assets -82.30% -85.38% -81.04% -53.87% -59.57%
Net Property, Plant & Equipment -54.40% -49.05% -33.57% -28.53% -23.87%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -60.71% -61.11% -58.80%
Total Assets -0.57% -11.28% -89.20% -86.38% -84.98%

Total Accounts Payable -13.62% -35.14% -9.18% 3.07% -22.46%
Total Accrued Expenses 4,815.31% 3,812.20% 167.54% 458.12% -81.04%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities 116.50% 87.74% -32.82% -18.37% -60.66%

Total Current Liabilities 116.50% 87.74% -32.82% -18.37% -60.66%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 723.12% 679.59% -32.82% -18.37% -60.66%

Common Stock & APIC -1.63% -3.25% 2.21% 9.77% 11.72%
Retained Earnings -2.72% -1.65% -47.27% -61.96% -67.91%
Treasury Stock & Other -2.58% -3.25% -1.14% 8.82% 10.55%
Total Common Equity -96.43% -92.88% -91.74% -89.03% -86.11%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -96.43% -92.88% -91.74% -89.03% -86.11%
Total Preferred Equity -- -- -- -- --
Total Minority Interest 3.85% 3.70% 0.00% -4.00% -4.00%
Total Equity -96.52% -92.96% -91.75% -89.04% -86.12%